Cargando…

Comparative effect of intraduodenal and intrajejunal glucose infusion on the gut–incretin axis response in healthy males

The region of enteral nutrient exposure may be an important determinant of postprandial incretin hormone secretion and blood glucose homoeostasis. We compared responses of plasma glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), insulin and glucagon, and blood gluc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, T, Thazhath, S S, Marathe, C S, Bound, M J, Jones, K L, Horowitz, M, Rayner, C K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450461/ https://www.ncbi.nlm.nih.gov/pubmed/25985092 http://dx.doi.org/10.1038/nutd.2015.6

Ejemplares similares

Disparities in the Glycemic and Incretin Responses to Intraduodenal Glucose Infusion Between Healthy Young Men and Women
por: Xie, Cong, et al.
Publicado: (2023)

Effects of Intraduodenal Glutamine on Incretin Hormone and Insulin Release, the Glycemic Response to an Intraduodenal Glucose Infusion, and Antropyloroduodenal Motility in Health and Type 2 Diabetes
por: Chang, Jessica, et al.
Publicado: (2013)

Ethnic disparities in insulin and glucose-dependent insulinotropic peptide (GIP) responses to intraduodenal glucose in health
por: Marathe, Chinmay S., et al.
Publicado: (2014)

Comparative effects of intraduodenal amino acid infusions on food intake and gut hormone release in healthy males
por: Steinert, Robert E., et al.
Publicado: (2017)

Comparative Effects of Intraduodenal Glucose and Fat Infusion on Blood Pressure and Heart Rate in Type 2 Diabetes
por: Xie, Cong, et al.
Publicado: (2020)

Effects of Intraduodenal Infusions of L-phenylalanine and L-glutamine on Antropyloroduodenal Motility and Plasma Cholecystokinin in Healthy Men
por: Steinert, Robert E, et al.
Publicado: (2015)

Effects of Intraduodenal Infusion of the Bitter Tastant, Quinine, on Antropyloroduodenal Motility, Plasma Cholecystokinin, and Energy Intake in Healthy Men
por: Bitarafan, Vida, et al.
Publicado: (2019)

Relationships Between Gastric Emptying, Postprandial Glycemia, and Incretin Hormones
por: Marathe, Chinmay S., et al.
Publicado: (2013)

Effects of GLP-1 and Incretin-Based Therapies on Gastrointestinal Motor Function
por: Marathe, Chinmay S., et al.
Publicado: (2011)

Dose-Dependent Effects of Randomized Intraduodenal Whey-Protein Loads on Glucose, Gut Hormone, and Amino Acid Concentrations in Healthy Older and Younger Men
por: Giezenaar, Caroline, et al.
Publicado: (2018)

Levodopa–carbidopa intrajejunal infusion in Parkinson’s disease: untangling the role of age
por: Morgante, Francesca, et al.
Publicado: (2020)

Intrajejunal Infusion of Levodopa/Carbidopa for Advanced Parkinson's Disease: A Systematic Review
por: Tsunemi, Taiji, et al.
Publicado: (2021)

Addition of Tolcapone in Intrajejunal Levodopa Infusion Therapy Requires a Pronounced Dose Reduction
por: Schröter, Nils, et al.
Publicado: (2020)

Long-term effects of intrajejunal levodopa infusion on sleep in people with advanced Parkinson's disease
por: Diaconu, Ştefania, et al.
Publicado: (2023)

Combined and Sequential Treatment with Deep Brain Stimulation and Continuous Intrajejunal Levodopa Infusion for Parkinson’s Disease
por: van Poppelen, Daniël, et al.
Publicado: (2021)

Contributions of upper gut hormones and motility to the energy intake‐suppressant effects of intraduodenal nutrients in healthy, lean men – a pooled‐data analysis
por: Schober, Gudrun, et al.
Publicado: (2016)

Relationships of the early insulin secretory response and oral disposition index with gastric emptying in subjects with normal glucose tolerance
por: Marathe, Chinmay S., et al.
Publicado: (2017)

Intrajejunal Infusion of Levodopa-Carbidopa Gel Can Continuously Reduce the Severity of Dropped Head in Parkinson’s Disease
por: Kataoka, Hiroshi, et al.
Publicado: (2017)

Intraduodenal Administration of L-Valine Has No Effect on Antropyloroduodenal Pressures, Plasma Cholecystokinin Concentrations or Energy Intake in Healthy, Lean Men
por: Elovaris, Rachel A., et al.
Publicado: (2019)

Intrajejunal migration of adjustable gastric band: a case report
por: Sapalidis, K., et al.
Publicado: (2013)

Incretin-based therapies: new treatments for type 2 diabetes in the new millennium
por: Khoo, Joan, et al.
Publicado: (2009)

Optimised endoscopic access for intrajejunal levodopa application in idiopathic Parkinson's syndrome
por: Grund, K. E., et al.
Publicado: (2023)

Artificial Sweeteners Have No Effect on Gastric Emptying, Glucagon-Like Peptide-1, or Glycemia After Oral Glucose in Healthy Humans
por: Wu, Tongzhi, et al.
Publicado: (2013)

Extensive Atrophic Gastritis Increases Intraduodenal Hydrogen Gas
por: Urita, Yoshihisa, et al.
Publicado: (2008)

Upper intestinal obstruction due to inverted intraduodenal diverticulum
por: Acosta-Merida, MA, et al.
Publicado: (2011)

Tolerability of overnight rotigotine transdermal patch combined with intrajejunal levodopa infusion at 1 year: a 24-h treatment option in Parkinson’s disease
por: Lau, Yue Hui, et al.
Publicado: (2022)

Simulation of Oral Glucose Tolerance Tests and the Corresponding Isoglycemic Intravenous Glucose Infusion Studies for Calculation of the Incretin Effect
por: Kim, Myeungseon, et al.
Publicado: (2014)

Intraduodenal Administration of Intact Pea Protein Effectively Reduces Food Intake in Both Lean and Obese Male Subjects
por: Geraedts, Maartje C. P., et al.
Publicado: (2011)

Plasma Free Amino Acid Responses to Intraduodenal Whey Protein, and Relationships with Insulin, Glucagon-Like Peptide-1 and Energy Intake in Lean Healthy Men
por: Luscombe-Marsh, Natalie D., et al.
Publicado: (2016)

Self-ingested intraduodenal foreign bodies – expectancy or surgical sanction?
por: Petrea, S, et al.
Publicado: (2014)

Comparative effects of small intestinal glucose on blood pressure, heart rate, and noradrenaline responses in obese and healthy subjects
por: Trahair, Laurence G., et al.
Publicado: (2018)

Role of Incretin Axis in Inflammatory Bowel Disease
por: Duan, Lihua, et al.
Publicado: (2017)

Protocol of a randomized open label multicentre trial comparing continuous intrajejunal levodopa infusion with deep brain stimulation in Parkinson’s disease - the INfusion VErsus STimulation (INVEST) study
por: van Poppelen, D., et al.
Publicado: (2020)

Intraduodenal sarcoma recurrence of retroperitoneal origin: an unusual cause for a duodenal obstruction
por: Bao, Jean J, et al.
Publicado: (2012)

Incretin responses to oral glucose load in Japanese non-obese healthy subjects
por: Nagai, Etsuko, et al.
Publicado: (2011)

Bone resorption and incretin hormones following glucose ingestion in healthy emerging adults
por: Lei, Wang Shin, et al.
Publicado: (2023)

Real‐life benefits of intrajejunal levodopa infusion therapy in four patients with the parkinsonian variant of progressive supranuclear palsy: A 1‐year follow‐up data report
por: Metta, Vinod, et al.
Publicado: (2022)

Effect of Glycemia on Plasma Incretins and the Incretin Effect During Oral Glucose Tolerance Test
por: Salehi, Marzieh, et al.
Publicado: (2012)

Intrajejunal vs oral levodopa-carbidopa therapy in Parkinson disease: A retrospective cohort study
por: Popa, Luminita C., et al.
Publicado: (2020)

Relationships of Glucose, GLP-1, and Insulin Secretion With Gastric Emptying After a 75-g Glucose Load in Type 2 Diabetes
por: Jalleh, Ryan J, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p0diggvoqqbaj7gum932lr3ph8